Foundation Fighting Blindness Retinal Degeneration Fund
SEC CIK 2042266 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Dir, See Remarks | 3.79M | — | $15.99M | 2 | 2025-12-09 | 2026-05-18 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 19:29 | 2026-05-18 | IRD | Opus Genetics, Inc. | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | S - Sale | $4.35 | -1.70M | 3.79M | -31% | -$7.39M | |
| 2025-12-11 | 2025-12-09 | IRD | Opus Genetics, Inc. | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | S - Sale | $2.15 | -4.00M | 5.49M | -42% | -$8.60M |
Purchase Sale Sale after option exercise All abbreviations